ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting

PURPOSE: The purpose of this study was to identify the excision repair cross-complementation group 1 (ERCC1) as a predictive marker for FOLFOX adjuvant chemotherapy in stages II and III colon cancer patients. METHODS: A total of 166 high risk stages II and III colon cancer patients were retrospectiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Coloproctol
Principais autores: Kim, Chee Young, Seo, Sang Hyuk, An, Min Sung, Kim, Kwang Hee, Bae, Ki Beom, Hwang, Jin Won, Kim, Ji Hyun, Kim, Bo Mi, Kang, Mi Seon, Oh, Min Kyung, Hong, Kwan Hee
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Coloproctology 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496459/
https://ncbi.nlm.nih.gov/pubmed/26161376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/ac.2015.31.3.92
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados